{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["3(Suppl 2)"],"submitter":["Taylor M"],"journal":["Journal for immunotherapy of cancer"],"pagination":["P376-P376"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC4649441"],"repository":["biostudies-literature"],"pubmed_title":["Phase I/II study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032"],"pmcid":["PMC4649441"],"pubmed_authors":["de Braud F","Horn L","Christensen O","Lopez-Martin J","Simon J","Morse M","Antonia S","Ascierto P","Taylor M","Jager D","Ott P","Pietanza M","Lin C","Bendell J","Le D","Eder J","Calvo E"],"additional_accession":[]},"is_claimable":false,"name":"Phase I/II study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032","description":null,"dates":{"release":"2015-01-01T00:00:00Z","publication":"2015 Jan","modification":"2025-04-26T19:29:54Z","creation":"2025-04-06T16:08:03.263Z"},"accession":"S-EPMC4649441","cross_references":{}}